Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival-Reference-Cited by-同舟云学术

Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival

Published:2018-02-26 Issue:4 Volume:7 Page:1118-1126
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Alonso Clayton¹,Dutta Sunil W.¹,Mitra Nandita²,Landsburg Daniel J.³,Zaorsky Nicholas G.⁴^ORCID,Grover Surbhi⁵,Peterson Jennifer⁶,Trifiletti Daniel M.⁶^ORCID

Affiliation:

1. Department of Radiation Oncology; University of Virginia; Charlottesville Virginia

2. Department of Biostatistics; University of Pennsylvania; Philadelphia Pennsylvania

3. Division of Hematology/Oncology; Department of Medicine; Hospital of the University of Pennsylvania; Philadelphia Pennsylvania

4. Department of Radiation Oncology; Pennsylvania State University; State Park Pennsylvania

5. Department of Radiation Oncology; Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania

6. Department of Radiation Oncology; Mayo Clinic; Jacksonville Florida

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1383/fullpdf

Reference19 articles.

1. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis;Gerber;Int. J. Radiat. Oncol. Biol. Phys.,2015

2. National Comprehensive Cancer Network Clinical Practice Guidelines: Hodgkin Lymphoma v 1.2017 https://www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf

3. Nodular lymphocyte predominant Hodgkin lymphoma;Lee;Oncologist,2009

4. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group;Engert;J. Clin. Oncol.,2003

5. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG);Nogova;Ann. Oncol.,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte‐predominant Hodgkin lymphoma: an IMPACT cohort study;British Journal of Haematology;2023-04-04

2. Cancer treatment and survivorship statistics, 2022;CA: A Cancer Journal for Clinicians;2022-06-23

3. Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All St AGE s : A consensus‐based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research Institute;British Journal of Haematology;2022-04

4. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW);Leukemia & Lymphoma;2022-03-31

5. Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up;Cancers;2021-04-07